CorMedix IncNASDAQ:CRMD
- LAST PRICE4.1800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.1600/ 25
- Ask / Lots4.2400/ 3
- Open / Previous Close4.2500 / 4.1800
- Day Range
- 52 Week Range
- Volume288,621
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 6782 | 4.21 |
| 09:34 ET | 200 | 4.23 |
| 09:41 ET | 100 | 4.22 |
| 09:43 ET | 1700 | 4.22 |
| 09:45 ET | 300 | 4.22 |
| 09:48 ET | 300 | 4.22 |
| 09:50 ET | 100 | 4.22 |
| 09:52 ET | 500 | 4.22 |
| 09:54 ET | 200 | 4.21 |
| 09:56 ET | 3330 | 4.2 |
| 09:57 ET | 600 | 4.18 |
| 10:01 ET | 400 | 4.1763 |
| 10:03 ET | 4121 | 4.1857 |
| 10:06 ET | 300 | 4.195 |
| 10:10 ET | 3395 | 4.2 |
| 10:17 ET | 100 | 4.215 |
| 10:19 ET | 100 | 4.215 |
| 10:21 ET | 100 | 4.215 |
| 10:24 ET | 100 | 4.215 |
| 10:28 ET | 109 | 4.21 |
| 10:30 ET | 236 | 4.22 |
| 10:32 ET | 1981 | 4.2 |
| 10:37 ET | 400 | 4.21 |
| 10:39 ET | 300 | 4.205 |
| 10:42 ET | 22547 | 4.215 |
| 10:44 ET | 4058 | 4.21 |
| 10:46 ET | 600 | 4.19 |
| 10:50 ET | 19292 | 4.21 |
| 10:51 ET | 400 | 4.205 |
| 10:53 ET | 100 | 4.205 |
| 10:55 ET | 1100 | 4.21 |
| 10:57 ET | 2400 | 4.23 |
| 11:00 ET | 1600 | 4.215 |
| 11:06 ET | 2515 | 4.245 |
| 11:09 ET | 100 | 4.255 |
| 11:11 ET | 100 | 4.2575 |
| 11:15 ET | 1258 | 4.25 |
| 11:20 ET | 200 | 4.255 |
| 11:22 ET | 822 | 4.245 |
| 11:24 ET | 100 | 4.24 |
| 11:27 ET | 300 | 4.235 |
| 11:31 ET | 1151 | 4.235 |
| 11:33 ET | 100 | 4.235 |
| 11:36 ET | 5400 | 4.235 |
| 11:38 ET | 700 | 4.2375 |
| 11:44 ET | 100 | 4.2375 |
| 11:45 ET | 200 | 4.235 |
| 11:47 ET | 100 | 4.2375 |
| 11:49 ET | 1100 | 4.225 |
| 11:54 ET | 100 | 4.2299 |
| 11:56 ET | 300 | 4.225 |
| 11:58 ET | 200 | 4.225 |
| 12:03 ET | 1100 | 4.225 |
| 12:07 ET | 250 | 4.225 |
| 12:09 ET | 300 | 4.23 |
| 12:12 ET | 200 | 4.225 |
| 12:14 ET | 144 | 4.2285 |
| 12:18 ET | 2304 | 4.225 |
| 12:20 ET | 100 | 4.225 |
| 12:25 ET | 200 | 4.215 |
| 12:30 ET | 200 | 4.21 |
| 12:32 ET | 100 | 4.2175 |
| 12:34 ET | 500 | 4.21 |
| 12:38 ET | 330 | 4.22 |
| 12:39 ET | 1300 | 4.215 |
| 12:41 ET | 100 | 4.21 |
| 12:43 ET | 100 | 4.21 |
| 12:45 ET | 100 | 4.21 |
| 12:48 ET | 400 | 4.215 |
| 12:50 ET | 1936 | 4.215 |
| 12:52 ET | 1244 | 4.235 |
| 12:54 ET | 114 | 4.2303 |
| 12:56 ET | 200 | 4.24 |
| 12:59 ET | 100 | 4.235 |
| 01:03 ET | 100 | 4.235 |
| 01:06 ET | 3400 | 4.235 |
| 01:08 ET | 266 | 4.24 |
| 01:12 ET | 713 | 4.255 |
| 01:14 ET | 300 | 4.26 |
| 01:15 ET | 200 | 4.26 |
| 01:24 ET | 234 | 4.265 |
| 01:26 ET | 100 | 4.265 |
| 01:28 ET | 1508 | 4.265 |
| 01:30 ET | 100 | 4.27 |
| 01:35 ET | 750 | 4.265 |
| 01:37 ET | 400 | 4.265 |
| 01:39 ET | 700 | 4.27 |
| 01:42 ET | 722 | 4.265 |
| 01:44 ET | 215 | 4.2759 |
| 01:48 ET | 500 | 4.28 |
| 01:50 ET | 500 | 4.275 |
| 01:51 ET | 2439 | 4.27 |
| 01:57 ET | 300 | 4.275 |
| 02:00 ET | 2705 | 4.26 |
| 02:02 ET | 100 | 4.265 |
| 02:04 ET | 100 | 4.265 |
| 02:08 ET | 200 | 4.27 |
| 02:09 ET | 100 | 4.265 |
| 02:11 ET | 100 | 4.265 |
| 02:15 ET | 1443 | 4.275 |
| 02:18 ET | 225 | 4.28 |
| 02:20 ET | 100 | 4.28 |
| 02:22 ET | 1540 | 4.265 |
| 02:24 ET | 900 | 4.265 |
| 02:26 ET | 300 | 4.26 |
| 02:27 ET | 100 | 4.265 |
| 02:31 ET | 200 | 4.265 |
| 02:36 ET | 2200 | 4.26 |
| 02:42 ET | 100 | 4.265 |
| 02:44 ET | 100 | 4.265 |
| 02:47 ET | 200 | 4.265 |
| 02:49 ET | 1868 | 4.235 |
| 02:51 ET | 100 | 4.235 |
| 02:54 ET | 300 | 4.24 |
| 02:56 ET | 900 | 4.24 |
| 03:00 ET | 100 | 4.245 |
| 03:02 ET | 1828 | 4.235 |
| 03:07 ET | 200 | 4.24 |
| 03:09 ET | 100 | 4.235 |
| 03:12 ET | 100 | 4.235 |
| 03:16 ET | 700 | 4.235 |
| 03:18 ET | 1100 | 4.235 |
| 03:20 ET | 100 | 4.235 |
| 03:21 ET | 100 | 4.235 |
| 03:23 ET | 4457 | 4.23 |
| 03:25 ET | 4661 | 4.235 |
| 03:27 ET | 2807 | 4.245 |
| 03:32 ET | 1035 | 4.24 |
| 03:34 ET | 1600 | 4.235 |
| 03:38 ET | 100 | 4.2375 |
| 03:39 ET | 500 | 4.235 |
| 03:41 ET | 100 | 4.235 |
| 03:43 ET | 700 | 4.235 |
| 03:45 ET | 200 | 4.235 |
| 03:48 ET | 4235 | 4.225 |
| 03:50 ET | 100 | 4.225 |
| 03:52 ET | 1094 | 4.225 |
| 03:54 ET | 1975 | 4.21 |
| 03:56 ET | 15080 | 4.2 |
| 03:57 ET | 9848 | 4.18 |
| 03:59 ET | 9488 | 4.18 |
Jun 19, 2024
DJ CorMedix Price Target Maintained With a $10.00/Share by Needham, from 5:55AM ET on Wednesday Jun 19, 2024 by Dow Jones
5:55AM ET on Wednesday Jun 19, 2024 by Dow Jones
Jun 18, 2024
CorMedix Inc. Receives FDA Feedback on Potential Label Expansion, from 8:00AM ET on Tuesday Jun 18, 2024 by Dow Jones
8:00AM ET on Tuesday Jun 18, 2024 by Dow Jones
Jun 6, 2024
CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath, from 8:30AM ET on Thursday Jun 06, 2024 by Dow Jones
8:30AM ET on Thursday Jun 06, 2024 by Dow Jones
May 28, 2024
CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider, from 8:30AM ET on Tuesday May 28, 2024 by Dow Jones
8:30AM ET on Tuesday May 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 233.7M | -4.5x | --- |
Cipla Ltd | 14.5B | 0.0x | --- |
Zevra Therapeutics Inc | 188.3M | -3.4x | --- |
Assembly Biosciences Inc | 96.0M | -1.4x | --- |
Calliditas Therapeutics AB | 1.2B | -20.8x | --- |
Incannex Healthcare Inc | 53.7M | 0.0x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Head of Clinical and Medical Affairs
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Commercial Officer
- Erin Mistry
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $233.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.60 |
EPS | $-0.93 |
Book Value | $1.28 |
P/E Ratio | -4.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
